228562-37-6

Basic information

• Product Name: 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-cyanoethyl)-ester 5-benzyl ester
• Synonyms: 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-cyanoethyl)-ester 5-benzyl ester
• CAS NO: 228562-37-6
• Molecular Weight: 450.922
• Mol File: 228562-37-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-cyanoethyl)-ester 5-benzyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-cyanoethyl)-ester 5-benzyl ester(228562-37-6)
• EPA Substance Registry System: 4-(3-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid 3-(2-cyanoethyl)-ester 5-benzyl ester(228562-37-6)

Safety Data

• Hazardous Substances Data: 228562-37-6(Hazardous Substances Data)

Upstream product

• 100-51-6 benzyl alcohol 
• 65193-87-5 2-cyanoethylacetoacetate 
• 5396-89-4 benzyl acetoacetate 
• 587-04-2 m-Chlorobenzaldehyde 
• 193539-61-6 (Z)-3-Amino-but-2-enoic acid 2-cyano-ethyl ester 

Downstream Products

• 228562-11-6 2-cyanoethyl 4-(3-chlorophenyl)-2,6-dimethyl-5-[3-(2-oxopyrrolidine-1-yl)propylcarbamoyl]-1,4-dihydropyridine-3-carboxylate 
• 228562-15-0 4-(3-chlorophenyl)-2,6-dimethyl-5-(3,3-diphenylpropylcarbamoyl)-1,4-dihydropyridine-3-carboxylic acid 

Relevant articles and documents

Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels

Cilnidipine is a 1,4-dihydropyridine derived L/N-type calcium channel dual blocker possessing neuroprotective and analgesic effects which are related to its N-type calcium channel inhibitory activity. In order to find specific N-type calcium channel blockers with the least effects on cardiovascular system, we performed structure-activity relationship study on APJ2708, which is a derivative of cilnidipine, and found a promising N-type calcium channel blocker 21b possessing analgesic effect in vivo with a 1600-fold lower activity against L-type calcium channels than that of cilnidipine.

NOVEL PYRIMIDINE DERIVATIVE AND NOVEL PYRIDINE DERIVATIVE

Achiral pyrimidine derivatives and pyridine derivatives of the following formulae or analogs thereof have selective N-type calcium channel antagonistic activity and showed analgesic action when they were taken orally. They are useful as therapeutic agents for pains and various diseases associated with the N-type calcium channels.

Dihydropyridine derivative

Dihydropyridine derivatives of the following formula, analogs thereof and pharmaceutically acceptable salts thereof have an activity of selectively inhibiting the action of N-type calcium channel. They are used as remedies for various diseases relating to the N-type calcium channel. STR1